found a significant correlation between NRG1 expression and tumor growth inhibition by the HER3 inhibitory antibody AV-203 [51], and another study demonstrated that HER3 inhibition could be quite effective in NRG1-rearranged cancers [52]. The gene discussed is NRG1; the disease is cancer.